{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:47:16Z","timestamp":1757616436016,"version":"3.44.0"},"reference-count":16,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Fam Plann Reprod Health Care"],"accepted":{"date-parts":[[2016,11,7]]},"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1136\/jfprhc-2016-101438","type":"journal-article","created":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T21:50:36Z","timestamp":1480110636000},"page":"160-161","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Postponing menstruation: choices and concerns"],"prefix":"10.1136","volume":"43","author":[{"given":"Diana","family":"Mansour","sequence":"first","affiliation":[{"name":"Consultant, Community Gynaecology and Reproductive Health Care, New Croft Centre, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2016,11,25]]},"reference":[{"key":"2025090510595816000_43.2.160.1","doi-asserted-by":"publisher","DOI":"10.1136\/jfprhc-2012-100345"},{"key":"2025090510595816000_43.2.160.2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/bmj.320.7230.291","article-title":"Is norethisterone a lifestyle drug? Results of database analysis","volume":"320","author":"Shakespeare","year":"2000","journal-title":"BMJ"},{"key":"2025090510595816000_43.2.160.3","unstructured":"Norethisterone tablets: Summary of Product Characteristics (revision of text 11.9.2015). https:\/\/www.medicines.org.uk\/emc\/medicine\/7257 [accessed 30 May 2016]."},{"key":"2025090510595816000_43.2.160.4","unstructured":"Depo-Provera 150\u2005mg\/ml injection: Summary of Product Characteristics. https:\/\/www.medicines.org.uk\/emc\/medicine\/11121 [accessed 30 May 2016]."},{"key":"2025090510595816000_43.2.160.5","unstructured":"Jaydess 13.5\u2005mg intrauterine delivery system: Summary of Product Characteristics. https:\/\/www.medicines.org.uk\/emc\/medicine\/28672 [accessed 30 May 2016]."},{"key":"2025090510595816000_43.2.160.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2011.12.003"},{"key":"2025090510595816000_43.2.160.7","unstructured":"Nexplanon 68\u2005mg implant for subdermal use: Summary of Product Characteristics. https:\/\/www.medicines.org.uk\/emc\/medicine\/23824\/SPC\/Nexplanon+68+mg+implant+for+subdermal+use\/ [accessed 30 May 2016]."},{"key":"2025090510595816000_43.2.160.8","unstructured":"Sayana Press 104\u2005mg\/0.65\u2005ml suspension for injection: Summary of Product Characteristics. https:\/\/www.medicines.org.uk\/emc\/medicine\/27798 [accessed 30 May 2016]."},{"key":"2025090510595816000_43.2.160.9","doi-asserted-by":"publisher","DOI":"10.1080\/13625180008500387"},{"key":"2025090510595816000_43.2.160.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2009.03.018"},{"key":"2025090510595816000_43.2.160.11","doi-asserted-by":"publisher","DOI":"10.3109\/13625187.2011.614029"},{"key":"2025090510595816000_43.2.160.12","doi-asserted-by":"publisher","DOI":"10.3109\/13625189809167250"},{"key":"2025090510595816000_43.2.160.13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1479-828X.1990.tb02028.x","article-title":"Treatment of ovulatory and anovulatory dysfunctional uterine bleeding with oral progestogens","volume":"30","author":"Fraser","year":"1990","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2025090510595816000_43.2.160.14","unstructured":"Faculty of Sexual and Reproductive Healthcare Clinical Effectiveness Unit. Combined Hormonal Contraception. October 2011. https:\/\/www.fsrh.org\/documents\/combined-hormonal-contraception\/ [accessed 1 June 2016]."},{"key":"2025090510595816000_43.2.160.15","unstructured":"Nuvaring: Summary of Product Characteristics. http:\/\/www.medicines.org.uk\/emc\/medicine\/21419\/SPC\/nuvaring\/ [accessed 30 May 2016]."},{"key":"2025090510595816000_43.2.160.16","unstructured":"Yasmin film-coated tablets 0.03\u2005mg\/3\u2005mg: Summary of Product Characteristics. https:\/\/ http:\/\/www.medicines.org.uk\/emc\/medicine\/8777 [accessed 30 May 2016]."}],"container-title":["Journal of Family Planning and Reproductive Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jfprhc-2016-101438","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T18:25:01Z","timestamp":1757096701000},"score":1,"resource":{"primary":{"URL":"https:\/\/jfprhc.bmj.com\/lookup\/doi\/10.1136\/jfprhc-2016-101438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,25]]},"references-count":16,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,4,11]]},"published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.1136\/jfprhc-2016-101438"],"URL":"https:\/\/doi.org\/10.1136\/jfprhc-2016-101438","relation":{},"ISSN":["1471-1893","2045-2098"],"issn-type":[{"type":"print","value":"1471-1893"},{"type":"electronic","value":"2045-2098"}],"subject":[],"published":{"date-parts":[[2016,11,25]]}}}